Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: thanks and here is a serious question ...

RE: thanks and here is a serious question ...

posted on Jun 15, 2006 01:21PM

from the PR

````The stock buyback plan adopted by the Board of Directors calls for management to use not less than 10 percent of future licensing revenue distributions received by the Company to purchase shares of our stock on the open market in a manner consistent with applicable securities laws and regulations,`` said David H. Pohl, Chairman and CEO of Patriot Scientific. ``These buybacks are, of course, subject to the Company determining at the time licensing revenue distributions are received that such action is prudent based upon market conditions and sound financial management considerations. Repurchased shares will be placed in our treasury as a resource available for possible future use,`` Pohl explained.``

I believe that to mean the shares remain authorized, but not in the float.

Corrections welcome.

John

Share
New Message
Please login to post a reply